These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29845680)

  • 1. Multiple sleep latency test in narcolepsy type 1 and narcolepsy type 2: A 5-year follow-up study.
    Huang YS; Guilleminault C; Lin CH; Chen CH; Chin WC; Chen TS
    J Sleep Res; 2018 Oct; 27(5):e12700. PubMed ID: 29845680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality.
    Ruoff C; Rye D
    Curr Med Res Opin; 2016 Oct; 32(10):1611-1622. PubMed ID: 27359185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1.
    Pizza F; Barateau L; Jaussent I; Vandi S; Antelmi E; Mignot E; Dauvilliers Y; Plazzi G;
    Neurology; 2019 Sep; 93(11):e1034-e1044. PubMed ID: 31405906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing MSLT Specificity in Narcolepsy With Cataplexy.
    Murer T; Imbach LL; Hackius M; Taddei RN; Werth E; Poryazova R; Gavrilov YV; Winkler S; Waldvogel D; Baumann CR; Valko PO
    Sleep; 2017 Dec; 40(12):. PubMed ID: 29069490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.
    Lopez R; Doukkali A; Barateau L; Evangelista E; Chenini S; Jaussent I; Dauvilliers Y
    Sleep; 2017 Dec; 40(12):. PubMed ID: 29099966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First rapid eye movement sleep periods and sleep-onset rapid eye movement periods in sleep-stage sequencing of hypersomnias.
    Drakatos P; Kosky CA; Higgins SE; Muza RT; Williams AJ; Leschziner GD
    Sleep Med; 2013 Sep; 14(9):897-901. PubMed ID: 23764105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
    Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underutilization of the MSLT in sleepy patients with a short onset REM period (SOREMP) in the sleep clinic.
    Cairns A; Bogan R
    Sleep Med; 2017 Apr; 32():150-156. PubMed ID: 28366327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.
    Aldrich MS; Chervin RD; Malow BA
    Sleep; 1997 Aug; 20(8):620-9. PubMed ID: 9351129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and sleep EEG monitoring characteristics and long-term follow-up study on narcolepsy].
    Wang R; Qin J; Liu XY; Feng BR
    Zhonghua Er Ke Za Zhi; 2003 Jan; 41(1):11-3. PubMed ID: 14761316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic delay in narcolepsy type 1: combining the patients' and the doctors' perspectives.
    Taddei RN; Werth E; Poryazova R; Baumann CR; Valko PO
    J Sleep Res; 2016 Dec; 25(6):709-715. PubMed ID: 27149919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remitting narcolepsy? Longitudinal observations in a hypocretin-deficient cohort.
    Büchele F; Baumann CR; Poryazova R; Werth E; Valko PO
    Sleep; 2018 Sep; 41(9):. PubMed ID: 29868885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ullanlinna Narcolepsy Scale in diagnosis of narcolepsy.
    Sarkanen T; Alakuijala A; Partinen M
    Sleep; 2019 Mar; 42(3):. PubMed ID: 30476331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What Does One Sleep-Onset REM Period—During Either Nocturnal Polysomnography or Multiple Sleep Latency Test—Mean in Differential Diagnosis of Central Hypersomnias?
    Bozluolcay M; Nalbantoglu M; Benbir Senel G; Karadeniz D
    J Clin Neurophysiol; 2015 Aug; 32(4):364-8. PubMed ID: 26241245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.